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Monodentate Secondary Phosphine Oxides, a New Class of Chiral
Ligands. Their Application in Ir (I)-Catalyzed Asymmetric Imine
Hydrogenation.
Xiao-bin Jiang a, Adriaan J. Minnaard a *, Bart Hessen a, Ben L. Feringa a *,
Alexander L. L. Duchateau b, Jean G. O. Andrien b, Jeroen A. F. Boogers b and
Johannes G. de Vries a, b *
Ligand Syntheses
Ligand 1 was prepared according to a literature procedure1. The ligands 2-7 were
prepared in a similar manner, modified to the extent that the Grignard reagent was added
to the solution of the RPCl2 (reverse addition).
iso-propylphosphinoyl-benzene (2) 2
Colorless oil, isolated yield 36%. 31P (CDCl3, 75MHz) δ 39.38 (s) 1H(CDCl3, 300MHz) δ
1.08 (dd, 3H, CH3, J=7.33, 9.15Hz), 1.14 (dd, 3H, CH3, J=7.32, 9.16Hz), 2.03-2.21 (m,
1H), 7.22 (dd, 1H, P-H, J=2.2, 458.28 Hz), 7.3-7.74 (m, 5H) 13C(CDCl3, 121MHz) δ
129.81, 127.71, 127.56, 126.50 (d, J =94Hz), 126.12, 125.96, 25.70 (d, J = 69.59Hz),
12.34, 11.76 HRMS (EI+) M+ for C9H13OP, 168.07264, calcd. 168.07040
The enantiomerically pure ligands were obtained by preparative HPLC, chiralpak AD
column, Preparative 250x20 mm ID flow 20 ml/min, RT, UV 254nm, n-hexane
/Ethanol=92.5/7.5, t1 =15.1min, [ ]D21 = -14.4o (C=0.25, CHCl3), t2 = 17.3min, [ ]D21 =
+11.2o (C=0.285, CHCl3)
2-tert-butylphosphinoyl-naphthalene (3)
White powder, isolated yield 14%. 31P (CDCl3, 75MHz) δ 47.03 (s) 1H(CDCl3, 300MHz)
δ 1.18 (d, 9H, 3CH3, J=16.6Hz), 7.17 (d, 1H, P-H, J P-H = 453.89Hz), 7.55-7.70 (m, 4H),
7.86-7.96 (m, 3H), 8.24 (d, 1H, J=14.41Hz) 13C(CDCl3, 121MHz) δ 133.54 (d,
J=12.56Hz), 131.37, 130.65, 127.17, 126.72, 126.40, 125.54, 124.23, 124.02, 123.51,
30.72 (d, J = 69.05Hz), 21.96 HRMS (EI+) M+ for C14H17OP 232.10117, calcd.
232.10170
The enantiomerically pure ligands were obtained by preparative HPLC, chiralpak AD
column, Preparative 250x20 mm ID flow 20 ml/min, RT, UV 254nm, n-hexane/ethanol =
67/33, t1 = 5.61min, mp 129-131oC, [ ]D21= -38.8o(C=0.245, CHCl3), t2 = 7.91min, mp
138-140oC, [ ]D21 = +38.5o (C=0.275, CHCl3)
2-methoxy-tert-butylphosphinoyl-benzene (4)
Colorless oil, isolated yield 68%. 31P (CDCl3, 75MHz) δ 35.58 (s) 1H(CDCl3, 300MHz) δ
1.15 (d, 9H, 3CH3, J=17.09Hz), 3.83 (s, 3H, OCH3), 6.86-6.93 (m, 1H), 7.01-7.08 (m,
1H), 7.36 (d, 1H, P-H, JP-H= 484.4Hz), 7.43-7.51(m, 1H), 7.63-7.73 (m, 1H) 13C(CDCl3,
121MHz) δ 159.35(d, J= 4.19 Hz), 132.42, 131.90, 119.14, 116.61, 109.05, 53.71, 30.92
(d, J=70.96Hz), 22.06 HRMS (EI+) M+ for C11H17O2P 212.09790, calcd. 212.09661
S 2
The enantiomerically pure ligands were obtained by preparative HPLC, chiralpak AD
column, Preparative 250x20 mm ID flow 20 ml/min, RT, UV 254nm, n-
hexane/ethanol=67/33, t1 =3.99min, [ ]D21= -15.1o (C=0.35, CHCl3), t2 = 5.88min, [ ]D21
= +11.8o (C=0.365, CHCl3).
(3,5-dimethyl)-tert-butylphosphinoyl-benzene (5)
White solid, isolated yield 65%. 31P (CDCl3, 75MHz) δ 47.76 (s) 1H(CDCl3, 300MHz) δ
1.13 (d, 9H, 3CH3, J=16.6Hz), 2.35 (s, 6H, 2CH3), 6.95 (d, 1H, P-H, JP-H = 452.42Hz),
7.17(s, 1H, CH), 7.28(s, 1H, CH), 7.22(s, 1H, CH) 13C (CDCl3, 121MHz) δ 136.65 (d, J
=12.59 Hz), 132.77, 127.30, 127.00, 126.79, 125.49, 30.24(d, J=69.05Hz), 21.87, 21.84,
19.62 HRMS (EI+) M+ for C12H19OP 210.11830, calcd. 210.11735
The enantiomerically pure ligands were obtained by preparative HPLC, chiralpak AD
column, Preparative 250x20 mm ID flow 20 ml/min, RT, UV 254nm, n-hexane
/Ethanol=92.5/7.5, t1 =7.23min, mp 144-147oC, [ ]D21 = +9.4o (C=0.265, CHCl3), t2 =
17.3min, mp 126-128oC, [ ]D21 = -9.8o (C=0.275, CHCl3).
(2,4,6-trimethyl)-tert-butylphosphinoyl-benzene (6)
Colorless oil, isolated yield 21% over 2 steps. 31P (CDCl3, 75MHz) δ 38.16 (s)
1H(CDCl3, 300MHz) δ 1.16 (d, 9H, 3CH3, JP-H = 16.6Hz), 2.22 (s, 3H, CH3), 2.49 (br,
6H, 2CH3), 6.83 (br, 2H, 2CH), 7.55 (d, 1H, P-H, JP-H = 455.59Hz) 13C(CDCl3, 121MHz)
δ 139.81, 139.77, 128.67, 128.12, 120.23 (d, J=88.12Hz), 32.70 (d, J= 69.05Hz), 22.78,
22.72, 20.45, 20.35, 19.12 HRMS (EI+) M+ for C13H21OP 224.13412, calcd. 224.13299
The enantiomerically pure ligands were obtained by preparative HPLC, chiralpak AD
column, Preparative 250x20 mm ID flow 20 ml /min, RT, UV 254nm, n-Heptane/2-
propanol=95/5, t1=8.971min, mp 109.5-112oC, [ ]D21 = -16.9o (C=0.255, CHCl3),
t2=13.728min, mp 105-107oC, [ ]D21 = +20.4o (C=0.275, CHCl3).
2-phenylphosphinoyl-naphthalene (7)
White solid, isolated yield 35%. 31P (CDCl3, 75MHz) δ 21.38 (s) 1H(CDCl3, 300MHz) δ
6.85-7.00 (m, 5H), 7.01-7.35 (m, 6H), 7.72 (d, 1H, P-H, J P-H = 483.18Hz), 7.90 (d, 1H,
J=15.63Hz) 13C(CDCl3, 121MHz) δ 133.07 (d, J=2.29Hz), 130.92, 130.71, 130.43,
128.91, 128.68, 127.74, 127.19, 126.94, 126.88, 126.57, 126.12, 125.73, 125.33, 123.309,
123.07 HRMS (EI+) M+ for C16H13OP 252.06907, calcd.252.07039
The enantiomerically pure ligands were obtained by preparative HPLC, chiralpak AD
column, Preparative 250x20 mm ID flow 20 ml/min, RT, UV 254nm, n-Hexane/2-
propanol=56/44, t1=22.4min, mp 73-75oC, [ ]D21= -5.2o (C=0.27, CHCl3), t2=26.859
min, mp 81-83oC, [ ]D21 = +6.0o(C=0.25, CHCl3) (lit. 3 mp184-186oC, No independent
measure of optical purity was given in this paper. In view of the low rotation reported the
material must have had very low optical purity., [ ]D = -0.59o,C=0.476, CHCl3 ).
(1R, 7R)-9,9-Dimethyl-4-hydrido-4-oxo-2, 2, 6, 6-tetraphenyl-3, 5, 8, 10-tetraoxa-4-
phosphabicyclo [5.3.0] decane (8)4
In a 100ml Schlenk vessel, was placed (4R, 5R)-4,5-bis-(hydroxy-diphenylmethyl)-[1,3]
dioxolane)(R,R-Taddol) (2mmol, 0.94g) and 5ml dry toluene. The solution was cooled
down to –78oC, and PCl3 (3.0mmol, 0.26ml) was added over 20mins. The solution was
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allowed to come to RT and stirring was continued for 3h. After cooling down to 0oC, 5ml
H2O was added slowly. After warming up to RT stirring was continued for 30mins. The
mixture was extracted with CH2Cl2 (3x10 ml), with brine (3x) and dried over MgSO4.
After removal of the solvent the residue was purified by flash chromatography (SiO2,
EtOAc/Hexane=1/1) to obtain a white powder; isolated yield 75%. Mp 224-226oC (dec.),
[ ]D21 =-268.4o (C=0.275, CHCl3), (lit. 4 mp 226-227oC, dec., [ ]D = -289.9 o, C=1.56,
CHCl3), 31P (CDCl3, 75MHz) δ -4.73, -4.79 (we presume the double peak is due to the
presence of two slowly interconverting conformers) 1H(CDCl3, 300MHz) δ 0.56 (s, 3H,
CH3), 0.76 (s, 3H, CH3), 5.21 (d, 1H, CH, J=7.82Hz), 5.36 (d, 1H, CH, J=8.06Hz), 7.08
(d, 1H, P-H, JP-H =726.85Hz), 7.23-7.46 (m, 16H), 7.56-7.63 (m, 4H)
13C(CDCl3,121MHz) δ 142.16 (d, J=2.68Hz), 141.65 (d, J=2.25Hz), 137.66 (d,
J=8.78Hz), 137.45 (d, J=6.48Hz), 127.31, 127.22, 127.00, 126.83, 126.70, 126.51,
126.40, 126.04, 125.86, 125.38, 125.30, 112.90, 87.31, 87.14, 78.57, 78.30, 25.28, 24.79
MS(CI+,%) 530(M+NH4+ ,100).
2, 5-diphenyl-phospholane-1-oxide (9)
This ligand was prepared according to a literature method5.
The pure enantiomers were obtained by preparative HPLC, chiralpak AD column,
Preparative 250x20 mm ID flow 20 ml/min, RT, UV 254nm, n-
heptane/isopropanol=75/25, t1=10.486min, t2=13.071min.
Imines
Imines were prepared from the ketones and the amines by azeotropic reflux in toluene
using molecular sieves 4Å. All imines are known compounds6 with the exception of 13.
(4-chlorophenyl)-N-[(E)-1-phenylethylidene]methanamine (13)
Isolated yield 44%, yellow oil, 1H (CDCl3, 300MHz) major isomer: δ 2.28 (s, 3H, CH3),
4.63 (s, 2H, CH2), 7.20-7.39 (m, 6H), 7.79-7.82 (m, 2H), 7.91 (d, 1H, J=7.32Hz) minor: δ
2.33, 4.88, 13C(CDCl3, 121MHz) major isomer: δ 165.53, 137.98, 130.78, 127.76,
127.29, 127.09, 126.91 125.40, 53.48, 16.83 minor: 164.69, 139.41, 127.83, 126.43,
124.45, 54.74, 14.44. In the 1H NMR and the 13C NMR some resonances of the minor
isomer are obscured. HRMS (EI+) C15H14NCl 243.08030, calcd. 243.08147
Typical procedure for imine hydrogenation
In a 5ml glass vial provided with a magnetic stirrer, a mixture of [Ir(COD)Cl]2 (3.4mg,
0.005mmol), SPO ligand (0.02 mmol), imine (0.5mmol) and pyridine (2eq. w.r.t. Ir, 2 l)
were dissolved in dry toluene (3ml). 7 of these vials were placed in an autoclave, which
was closed, purged 3 times with N2 and 3 times with H2. The autoclave was pressurized
with H2 to 20-25bar and the reactions were magnetically stirred at room temperature
(unless noted otherwise). After the desired time, the autoclave was opened. The solvent in
each vial was transferred to a 10ml round bottle and the solvent was removed under
vacuum. Degree of conversion and selectivity was determined by 1H NMR (CDCl3). For
the e.e. determination the amines were converted to their N-acetyl derivatives with 50 l
Ac2O. After filteration on a short silica gel column the filtrate was analysed by HPLC
(chiralpak AD or OD column). The absolute configuration was determined by comparing
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with commercially available enatiomerically pure products. Racemic samples were
prepared by NaBH4 reduction of imines in ethanol as solvent for 30 minutes.
Table 1 HPLC data of N-acetyl derivatives of hydrogenation products a
Name Column Condition t (min) t (min)
Amine 10(N-acetyl) OD 250x4.6 Hep/IPA 95/5 t R=11.573 t S=14.101
Amine 11(N-acetyl) AD 250x4.6 Hep/IPA 95/5 t1=16.821 t2=18.955
Amine 12(N-acetyl) AD 250x4.6 Hep/IPA 95/5 t1=14.827 t2=17.173
Amine 13(N-acetyl) AD 250x4.6 Hep/IPA 95/5 t1=11.403 t2=13.685
Amine 14(N-acetyl) AD 250x4.6 Hep/IPA 95/5 t1=12.544 t2=13.803
Amine 15(N-acetyl) OD 250x4.6 Hep/IPA 95/5 t1=10.731 t2=15.307
Amine 16(free amine) Wh01 250x4.6 Hep/EtOH 90/10 t1=6.603 t2=8.651
Amine 17(free amine) OD 250x4.6 Hep/IPA 90/10 t1=6.843 t2=8.122
a General conditions for HPLC: flow rate 1.0ml/min, RT, UV 220 nm
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